A 3′-truncating FTL mutation associated with hypoferritinemia without neuroferritinopathy

Stefanie Turner, Carolyn Dress, Vinod K. Misra

Research output: Contribution to journalArticlepeer-review


Mutations in the gene for the ferritin light chain (FTL) often present with hypoferritinemia associated with progressive, late onset extrapyramidal dysfunction. However, it has been suggested that some FTL mutations may impact ferritin levels without any neurological manifestations. We report on a FTL mutation in a three generation family with autosomal dominant hypoferritinemia without neurodegeneration. The 4 year old proband was identified with longstanding history of hypoferritinemia without evidence of anemia. Brain MRI did not show any evidence of iron deposition. It was found that the patient's 19 month old sister, 30 year old mother and 58 year old maternal grandmother also had hypoferritinemia and normal iron levels. Over the next nine years, none of these persons had any evidence of neurological dysfunction, including movement disorders, gait disturbances, behavioral or psychiatric dysfunction. Whole exome sequencing revealed a heterozygous interstitial deletion of at least 5 kb within cytogenic band 19q13.33 involving exons 3 and 4 of FTL in all affected family members. This 3′ FTL deletion is predicted to create a significantly truncated protein product. We conclude that haploinsufficiency of FTL may be associated with hypoferritinemia without neurological dysfunction.

Original languageEnglish
Article number104159
JournalEuropean Journal of Medical Genetics
Issue number3
StatePublished - Mar 2021
Externally publishedYes


  • FTL
  • Ferritin
  • Haploinsufficiency
  • Hypoferritinemia
  • Neuroferritinopathy


Dive into the research topics of 'A 3′-truncating FTL mutation associated with hypoferritinemia without neuroferritinopathy'. Together they form a unique fingerprint.

Cite this